Search Results - "Abdo Filho, Elias"

Neoadjuvant Chemotherapy With Cisplatin and Gemcitabine Followed by Chemoradiation Versus Chemoradiation for Locally Advanced Cervical Cancer: A Randomized Phase II Trial by da Costa, Samantha Cabral S, Bonadio, Renata Colombo, Gabrielli, Flavia Carolina G, Aranha, Andrea S, Dias Genta, Maria Luiza N, Miranda, Vanessa C, de Freitas, Daniela, Abdo Filho, Elias, Ferreira, Patrícia A O, Machado, Karime K, Scaranti, Mariana, Carvalho, Heloísa de A, Estevez-Diz, Maria Del Pilar

“…Although chemoradiation therapy (CRT) with cisplatin remains the standard treatment of patients with locally advanced cervical cancer (LACC), 40% of patients…”
Get full text

Neoadjuvant chemotherapy with six cycles of carboplatin and paclitaxel in advanced ovarian cancer patients unsuitable for primary surgery: Safety and effectiveness by da Costa Miranda, Vanessa, de Souza Fêde, Ângelo Bezerra, dos Anjos, Carlos Henrique, da Silva, Juliana Ribeiro, Sanchez, Fernando Barbosa, da Silva Bessa, Lyvia Rodrigues, de Paula Carvalho, Jesus, Filho, Elias Abdo, de Freitas, Daniela, Del Pilar Estevez Diz, Maria

“…Abstract Objective Three cycles of neoadjuvant chemotherapy (NACT) followed by interval debulking (ID) surgery is an alternative for patients with advanced…”
Get full text

Carboplatin-based chemoradiotherapy in advanced cervical cancer: an alternative to cisplatin-based regimen? by Sebastião, Ana Morais, Rocha, Lucila Soares da Silva, Gimenez, Rodrigo Darouche, Barros, Laryssa Almeida Borges de, Fukushima, Julia Tizuko, Silva, Samantha Cabral Severino da, Miranda, Vanessa da Costa, Caires, Inacelli Queiros de Souza, de Freitas, Daniela, Filho, Elias Abdo, Diz, Maria Del Pilar Estevez

“…Abstract Objective To evaluate the results of treatment with cisplatin or carboplatin concomitant with radiotherapy (RT) in cases of locally advanced cervical…”
Get full text

Adjuvant Carboplatin and Paclitaxel Chemotherapy Followed by Radiotherapy in High-Risk Endometrial Cancer: A Retrospective Analysis by Rodrigues da Cunha Colombo Bonadio, Renata, Gondim Meira Velame Azevedo, Renata, Harada, Guilherme, Cabral Severino da Costa, Samantha, Costa Miranda, Vanessa, de Freitas, Daniela, Abdo Filho, Elias, Alves de Oliveira Ferreira, Patricia, Gabrielli, Flavia, Del Pilar Estevez Diz, Maria

“…The best adjuvant treatment in high-risk endometrial cancer remains unclear. Although adjuvant chemotherapy seems to improve overall survival (OS) in locally…”
Get full text

Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial by Poveda, Andrés, Floquet, Anne, Ledermann, Jonathan A, Penson, Richard T, Oza, Amit M, Korach, Jacob, Huzarski, Tomasz, Pignata, Sandro, Friedlander, Michael, Baldoni, Alessandra, Park-Simon, Tjoung-Won, Tamura, Kenji, Lisyanskaya, Alla, Kim, Jae-Hoon, Filho, Elias Abdo, Milenkova, Tsveta, Lowe, Elizabeth S, Rowe, Phil, Pujade-Lauraine, Eric, Korach, Jacob, Huzarski, Tomasz, Byrski, Tomasz, Pautier, Patricia, Harter, Philipp, Colombo, Nicoletta, Pignata, Sandro, Scambia, Giovanni, Nicoletto, Maria, Nussey, Fiona, Clamp, Andrew, Penson, Richard, Rodrigues, Manuel, Lotz, Jean-Pierre, Selle, Frédéric, Ray-Coquard, Isabelle, Provencher, Diane, Prat Aparicio, Aleix, Yunokawa, Mayu, Lisyanskaya, Alla, Medioni, Jacques, Pécuchet, Nicolas, Dubot, Coraline, Kaminsky, Marie-Christine, Weber, Béatrice, Parkinson, Christine, Ledermann, Jonathan, Williams, Sarah, Banerjee, Susana, Cosin, Jonathan, Hoffman, James, Plante, Marie, Covens, Allan, Sonke, Gabe, Joly, Florence, Floquet, Anne, Hirte, Holger, Amit, Amnon, Matsumoto, Koji, Tjulandin, Sergei, Gladieff, Laurence, Sabbatini, Roberto, O'Malley, David, Timmins, Patrick, Kredentser, Daniel, Laínez Milagro, Nuria, Tibau Martorell, Ariadna, Gómez De Liaño Lista, Alfonso, Ojeda González, Belén, Mandai, Masaki, Boere, Ingrid, Ottevanger, Petronella, Nam, Joo-Hyun, Filho, Elias, Hamizi, Salima, Cognetti, Francesco, Warshal, David, Dickson-Michelson, Elizabeth, Kamelle, Scott, Rodriguez, Gustavo, Celano, Paul, Behbakht, Kian, Davidson, Susan, Helpman, Limor, Fishman, Ami, Bruchim, Ilan, Sikorska, Magdalena, Słowińska, Anna, Rogowski, Wojciech, Śpiewankiewicz, Beata, Casado Herraez, Antonio, Mendiola Fernández, César, Saito, Toshiaki, Takehara, Kazuhiro, Enomoto, Takayuki, Watari, Hidemichi, Choi, Chel Hun, Kim, Byoung-Gie, Weon Kim, Jae, Hegg, Roberto, Vergote, Ignace

“…Olaparib, a poly (ADP-ribose) polymerase (PARP) inhibitor, has previously been shown to extend progression-free survival versus placebo when given to patients…”
Get full text

A phase II trial of palbociclib combined to letrozole after progression on second-line chemotherapy for women with ER/PR-positive high-grade serous or endometrioid ovarian, fallopian tube, or peritoneal cancer: LACOG 1018 by Damian, Fernanda Bronzon, Melo, Andreia Cristina De, Zibetti Dal Molin, Graziela, Rodrigues, Angelica Nogueira, Calabrich, Aknar Freire de Carvalho, Werutsky, Gustavo, Filho, Elias Abdo, Rebelatto, Taiane Francieli, de Jesus, Rafaela Gomes, Jimenez, Mirela Foresti

“…5514 Background: Treatment options for patients with high-grade ovarian serous (HGSC) or endometrioid carcinoma (HGEC) who progress after receiving…”
Get full text

Final overall survival (OS) results from SOLO2/ENGOT-ov21: A phase III trial assessing maintenance olaparib in patients (pts) with platinum-sensitive, relapsed ovarian cancer and a BRCA mutation by Poveda, Andres, Floquet, Anne, Ledermann, Jonathan A., Asher, Rebecca, Penson, Richard T., Oza, Amit M., Korach, Jacob, Huzarski, Tomasz, Pignata, Sandro, Friedlander, Michael, Baldoni, Alessandra, Park-Simon, Tjoung-Won, Sonke, Gabe S., Lisyanskaya, Alla Sergeevna, Kim, Jae-Hoon, Filho, Elias Abdo, Vergote, Ignace, Rowe, Phil, Pujade-Lauraine, Eric

“…Abstract only 6002 Background: SOLO2 (ENGOT ov-21; NCT01874353) showed that maintenance therapy with the PARP inhibitor olaparib in pts with platinum-sensitive…”
Get full text

Olaparib Tablets as Maintenance Therapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer and a BRCA1/2 Mutation (SOLO2/ENGOT-Ov21): A Final Analysis of a Double-Blind, Randomised, Placebo-Controlled, Phase 3 Trial by Poveda, Andrés, Floquet, Anne, Ledermann, Jonathan A., Asher, Rebecca, Penson, Richard T., Oza, Amit M., Korach, Jacob, Huzarski, Tomasz, Pignata, Sandro, Friedlander, Michael, Baldoni, Alessandra, Park-Simon, Tjoung-Won, Tamura, Kenji, Sonke, Gabe S., Lisyanskaya, Alla, Kim, Jae-Hoon, Filho, Elias Abdo, Milenkova, Tsveta, Lowe, Elizabeth S., Rowe, Phil, Vergote, Ignace, Pujade-Lauraine, Eric

“…(Abstracted from Lancet Oncol 2021;22:620–631) The poly (ADP-ribose) polymerase (PARP) inhibitor olaparib is approved as maintenance therapy in newly diagnosed…”
Get full text

Neoadjuvant chemotherapy with cisplatin and gemcitabine followed by chemoradiation with cisplatin in locally advanced cervical cancer: A phase II, prospective, randomized, trial by Silva, Samantha, Colombo Bonadio, Renata RC, Gabrielli, Flavia, Aranha, Andrea souza, Genta, Maria Luiza, Miranda, Vanessa Costa, Freitas, Daniela, Filho, Elias Abdo, Ferreira, Patricia Alves De Oliveira, Kalil, Karime, Scaranti, Mariana, Estevez-Diz, Maria Del Pilar

“…Abstract only…”
Get full text

Adjuvant carboplatin and paclitaxel chemotherapy followed by radiotherapy in high-risk endometrial cancer: A retrospective analysis by Colombo Bonadio, Renata RC, Azevedo, Renata Gondim Meira Velame, Harada, Guilherme, Miranda, Vanessa Costa, Ferreira, Patricia Alves de Oliveira, Freitas, Daniela, Filho, Elias Abdo, Gabrielli, Flavia, Estevez-Diz, Maria Del Pilar, Costa, Samantha Cabral Severino da

“…Abstract only e17115 Background: It remains unclear which is the best chemotherapy (CT) regimen and what is the role of adding radiotherapy (RT) to adjuvant CT…”
Get full text

Ovarian adenosarcoma simulating a simple cyst in a young patient by Leonardo Gomes da Fonseca, Aloisio Felipe-Silva, Samanta Cabral Severino da Silva, Paulo Francisco Ramos Margarido, Elias Abdo Filho, Paulo Marcelo Gehm Hoff

“…Müllerian adenosarcoma is a rare, mixed tumor that can occur throughout the female genital tract, but is most commonly found in the uterus. Ovarian…”
Get full text

Ovarian adenosarcoma simulating a simple cyst in a young patient by da Fonseca, Leonardo Gomes, Felipe-Silva, Aloísio, da Silva, Samanta Cabral Severino, Margarido, Paulo Francisco Ramos, Abdo, Filho, Elias, Hoff, Paulo Marcelo Gehm

“…Müllerian adenosarcoma is a rare, mixed tumor that can occur throughout the female genital tract, but is most commonly found in the uterus. Ovarian…”
Get full text

Carboplatin-based chemoradiotherapy in advanced cervical cancer: An alternative to cisplatin-based regimen? by Sebastião, Ana Morais, Rocha, Lucila Soares Da Silva, Gimenez, Rodrigo Darouche, Caires, Inacelli Queiroz De Souza, Silva, Samantha Cabral Severino da, Barros, Laryssa Almeida Borges de, Fukushima, Julia Tizue, Miranda, Vanessa Costa, Filho, Dr Elias Abdo, Freitas, Daniela, Estevez-Diz, Maria Del Pilar

“…Abstract only…”
Get full text

Neoadjuvant chemotherapy with six cycles of carboplatin and paclitaxel in advanced ovarian cancer patients not candidates for optimal primary surgery: Safety and effectivenes by Miranda, Vanessa Costa, Fede, Angelo Bezerra de Sousa, Dos Anjos, Carlos Henrique, da Silva, Juliana Ribeiro, Sanchez, Fernando Barbosa, Bessa, Lyvia Rodrigues da Silva, Carvalho, Jesus Paula, Filho, Dr Elias Abdo, Freitas, Daniela, Barros, Laryssa Almeida Borges de, Silva, Samantha Cabral Severino da, Estevez-Diz, Maria Del Pilar

“…Abstract only 5540 Background: Primary debulking surgery (PDS) has been considered the standard of treatment in advanced ovarian cancer, while neoadjuvant…”
Get full text